MAKING THE CONNECTION
Between Patients and Providers VIRTUAL EDITION
A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes
DECEMBER 11, 2021 | 9:00AM - 4:15PM PT
Interactive 6-hour Program
Earn Educational Credits
Live Q+A With Expert Speakers
Network with Professionals
Lectures On-Demand 30 Days*
An interactive EDUCATIONAL conference experience for Healthcare Professionals FROM AROUND THE WORLD…with expert speakers, re-watchable lectures and live Q&A during every presentation!
Stay updated on the latest information and cutting-edge research in treating type 1 and type 2 diabetes while learning the best practices to open two-way communication with your patients and improve long-term outcomes. Check out educational and entertaining lectures presented by our world-renowned speakers with real experience (many who live with diabetes themselves) and participate in Live Q&A in every session. Don’t forget to network with our international community of healthcare professionals. End the day with practical knowledge to advance your practice.
This is a 6-hour interactive program, please see the full accreditation information here.
WHEN – SATURDAY, DECEMBER 11, 2021
Conference Program: 9:00am – 4:15pm PT
Exhibit Hall & Networking Opportunities: 8:00 – 9:00am, 11:30am – 12:00pm, 1:30 – 2:00pm PT
WHERE – VIRTUAL!
This event will be hosted online. All registered participants will receive an email the week of the event with a link and instructions to participate.
HOW MUCH – $25
Held in conjunction with the CME program, it’s life-changing day of education, motivation and empowerment to give people living with diabetes the tools they need to take a more active role in their health.
Looking for detailed conference schedule and speaker information?
Presenter Slide Decks
Download the presentation slide decks ahead of time
and save them to your laptop or tablet!
**NOTE: Adding event to your calendar does not register you for the event. To register, please click “REGISTER NOW” button.**
We focus on five distinct areas of the most cutting-edge diabetes management strategies:
1. Understanding the emotional and behavioral issues that affect adherence and glycemic control in people living with diabetes
2. Lowering Cardiorenal Risk While Improving Glycemic Control with oral agents: Understanding and effective use of the new ADA treatment algorithm.
3. Practical Application of individualized insulin strategies and a close look at the cardiovascular effects of the GLP1-RAs
4. A Focus on Time in Range, Unmet Needs & Modern Management of Type 1 Diabetes: continuous glucose monitors, insulin pumps, hybrid closed loop systems, adjunctive therapies and techniques to improve time in range
5. Diabetes criminals and the diabetes police: A workshop to focus on the provider patient relationship
MTC LEARNING OBJECTIVES
Upon completion of these activities, participants should be able to:
• Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.
• Discuss the recently published cardiovascular-renal outcome trials on oral (SGLT2 inhibitors) and injectable type 2 medications (GLP1-RAS).
• Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).
• Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.
• Design a treatment plan for multiple daily injection regimens and insulin pump therapy including hybrid closed loop systems.
• Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.
• Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
• Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.
EXPERT SPEAKERS & STATE-OF-THE-ART PRESENTATIONS – A rare opportunity to get advanced education through interactive presentations presented by the nation’s leading experts and key opinion leaders in diabetes care from the comfort of home.
LIVE Q&A DISCUSSIONS – A unique live discussion where you can get your questions answered in real-time by seasoned healthcare professionals with real experience (many of our speakers live with diabetes themselves).
NETWORKING ON AN INTERNATIONAL LEVEL – Interact and engage with healthcare providers from all over the world to share your ideas, expand upon your knowledge, and make professional connections.
EARN EDUCATIONAL CREDITS – Get credits and finish the program with practical knowledge to implement into your practice. This is a 6-hour interactive program, please see the full accreditation information here.
30 DAYS OF INFORMATIONAL LECTURES – Enjoy 30 days to re-watch all recorded educational lectures presented by TCOYD’s powerhouse faculty of medical experts.*
*If you have already participated in a 2021 Making the Connection event, you cannot claim credit twice
*If you miss any content during the live, virtual event, you may watch recorded content and claim credit for up to 30 days after the event. Pre-registration is required.
“The program was well organized and went from the basics to the complex. An awesome program that kept me glued to the computer!”
|9:00AM - 10:15AM||Program Overview & Introduction – Steven V. Edelman, MD
Understanding the Emotional and Behavioral Issues that Affect Adherence and Glycemic Control in People Living with Diabetes – William Polonsky, PhD, CD
|10:15AM - 11:30AM||A Focus on Time in Range, Unmet Needs and Modern Management of Type 1 Diabetes – Jeremy H. Pettus, MD
Continuous Glucose Monitors, Insulin Pumps, Hybrid Closed Loop Systems, Adjunctive Therapies and Techniques to Improve Time in Range.
|11:30AM - 12:00PM||BREAK
Rest, stretch, relieve…whatever you need
|12:00PM - 1:30PM||Lowering Cardiorenal Risk While Improving Glycemic Control with Oral Agents: Understanding and Effective Use of the New ADA Treatment Algorithm – Juan Pablo Frias, MD|
|1:30PM - 2:00PM||BREAK
Rest, stretch, relieve…whatever you need
|2:00PM - 3:15PM||Practical Application of Individualized Insulin Strategies and a Close Look at the Cardiovascular Effects of the GLP1-RAs – Steven V. Edelman, MD|
|3:15PM - 4:15PM||Diabetes Criminals and The Diabetes Police: A Workshop to Focus on the Provider Patient Relationship – William Polonsky, PhD, CDE, and Steven V. Edelman, MD|
*Steven V. Edelman, MD
TCOYD Founder & Director
Dr. Edelman is the founder and director of Taking Control Of Your Diabetes (TCOYD), a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. He is also the director of the Diabetes Care Clinic at the VA Medical Center. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report.
*Jeremy Pettus, MD
Type 1 Track and Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him as our Type 1 Track director. Dr. Pettus travels across the country and the world meeting other leading physicians and scientists and brings this information directly to TCOYD conference participants.
William Polonsky, PhD, CDCES
Clinical Psychologist; Founder & CEO, Behavioral Diabetes Institute
Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, the world's first organization totally dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Psychiatry at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. A licensed clinical psychologist and certified diabetes educator, he received the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology. Dr. Polonsky’s most recent research projects have focused on quality of life in diabetes, diabetes-related distress and depression, hypoglycemic fear, and glucose monitoring behavior and attitudes in people living with diabetes.
Juan Pablo Frias, MD
CEO, Principal Investigator, National Research Institute
Dr. Frias, a native of Chile, is currently President and Principal Investigator of National Research Institute in Los Angeles, CA. He completed his undergraduate studies at the University of Florida and received his medical degree from Vanderbilt University School of Medicine. After serving 5 years as a General Medical Officer in the US Navy, he completed his training in Internal Medicine at Vanderbilt University and the University of Tennessee, and his Fellowship in Endocrinology, Diabetes and Metabolism at the University of California, San Diego. Dr. Frias has held leadership positions in Clinical and Medical Affairs at Eli Lilly, Amylin Pharmaceuticals, Pfizer, and Johnson and Johnson, where he served as Chief Medical Officer and Global Vice President of Clinical and Medical Affairs, Diabetes Care. He has held academic positions at the University of Colorado Health Sciences Center, Barbara Davis Center for Diabetes, and the University of California San Diego School of Medicine, where he is currently on the clinical faculty. Dr. Frias has been involved in diabetes and metabolism-related research for over 20 years and has authored numerous publications in this field.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California San Diego School of Medicine and Taking Control of Your Diabetes. The University of California San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
AMA: The University of California San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 6.0 hours of credit and list “CME Category 1” as the provider number).
Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.
Certified Diabetes Care and Education Specialists: To satisfy the requirement for renewal of certification by continuing education for the Certification Board for Diabetes Care and Education (CBDCE) continuing education activities must be diabetes related and approved for a provider on the CBDCE list of approved providers (cbdce.org). CBDCE does not approve continuing education. The University of California San Diego is accredited by the ACCME, which is on the CBDCE list of approved providers.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-21-015-L01-P)
This is a knowledge based activity.
Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.
Cancellation Refund Policy
Need to cancel? Email us at firstname.lastname@example.org
To receive a full refund, cancellations must be received no later than December 7, 2021.
GET YOUR CME CREDITS HERE!
Attend the Conference. Get the Code. Get Your Credits!
After you have attended the Making the Connection conference click below to claim your CME credit. Be sure to reference your credit access code, found in the materials you will receive on the day of the conference.